Free shipping on all orders over $ 500

AZD-5153 HNT salt

Cat. No. M9026
AZD-5153 HNT salt Structure


Size Price Availability Quantity
5mg USD 150 In stock
10mg USD 260 In stock
25mg USD 500 In stock
50mg USD 940 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control
  • Current batch:
  • Purity >98%
  • COA
  • MSDS
Biological Activity

AZD-5153 HNT salt is a 6-hydroxy-2-naphthoic acid salt of AZD-5153. AZD5153 efficiently down-regulates MYC protein levels across the cell line panel irrespective of their sensitivity to AZD5153.

In vivo, administration of AZD5153 leads to tumor stasis or regression in multiple xenograft models of acute myeloid leukemia, multiple myeloma, and diffuse large B-cell lymphoma. AZD5153 modulates MYC and HEXIM1 in AML xenograft tumors and human whole blood. AZD5153 treatment markedly impacts transcriptional programs of MYC, E2F and mTOR.

Cell Experiment
Cell lines MV-4-11, MM.1S, and K562 cells
Preparation method Apoptosis was analyzed by flow cytometry using CellEvent Caspase 3/7 Green detection reagent. MV-4-11, MM.1S, and K562 cells were pretreated with AZD5153 or I-BET762 for 48 hours in culture media. Cells were collected and stained with 5 μmol/L final concentration of CellEvent for 30 minutes at 37°C. Flow cytometry was done on a BD Fortessa using the Blue laser and FITC filter set.
Incubation time 48 h
Animal Experiment
Animal models Female CB17 SCID and SCID beige mice
Formulation 0.5% hydroxymethylcellulose, 0.1% Tween80 (oral); 20% v/v DMSO/60% v/v HP-B-CD in water (s.c)
Administration by oral gavage mini-pump infusion or s.c
Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Chemical Information
Molecular Weight 667.75
Formula C25H33N7O3.C11H8O3
CAS Number 1869912-40-2
Purity >98%
Solubility DMSO: ≥ 30 mg/mL
Storage at -20°C

Translational Modeling of Drug-Induced Myelosuppression and Effect of Pretreatment Myelosuppression for AZD5153, a Selective BRD4 Inhibitor.
Collins TA, et al. CPT Pharmacometrics Syst Pharmacol. 2017 Jun;6(6):357-364. PMID: 28378926.

Identification of CCR2 and CD180 as Robust Pharmacodynamic Tumor and Blood Biomarkers for Clinical Use with BRD4/BET Inhibitors.
Yeh TC, et al. Clin Cancer Res. 2017 Feb 15;23(4):1025-1035. PMID: 28073847.

AZD5153: A Novel Bivalent BET Bromodomain Inhibitor Highly Active against Hematologic Malignancies.
Rhyasen GW, et al. Mol Cancer Ther. 2016 Nov;15(11):2563-2574. PMID: 27573426.

Optimization of a Series of Bivalent Triazolopyridazine Based Bromodomain and Extraterminal Inhibitors: The Discovery of (3R)-4-[2-[4-[1-(3-Methoxy-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)-4-piperidyl]phenoxy]ethyl]-1,3-dimethyl-piperazin-2-one (AZD5153).
Bradbury RH, et al. J Med Chem. 2016 Sep 8;59(17):7801-17. PMID: 27528113.

Related Epigenetic Reader Domain Products

AZD5153 is a potent bivalent triazolopyridazine based Bromodomain and Extraterminal (BET) Inhibitor, with IC50 value of 5 nM.


MS417 (also known as GTPL7512) is a potent and selective BRD4 inhibitor, which binds to BRD4-BD1 and BRD4-BD2 with IC50s of 30 and 46 nM, respectively.


FL-411 is a selective BRD4 inhibitor.


dBET6 is a highly potent, selective and cell-permeable degrader of BET with an IC50 of 14 nM.


dBET1 is a potent BRD4 protein degrader with an EC50 of 430 nM.

Abmole Inhibitor Catalog 2017

Keywords: AZD-5153 HNT salt, AZD5153 supplier, Epigenetic Reader Domain, inhibitors

Contact Us

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2020 AbMole BioScience. All Rights Reserved.